|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current assets: | |||||||||||||
| Other receivables | |||||||||||||
| Cash | |||||||||||||
| Prepaid expenses | |||||||||||||
| Short-term investments – related party | |||||||||||||
| Total current assets | |||||||||||||
| Deferred financing costs, net | |||||||||||||
| Operating lease, right of use assets | |||||||||||||
| Nonrelated Party | |||||||||||||
| Total operating lease, right of use assets | |||||||||||||
| Related party receivable | |||||||||||||
| Related Party | |||||||||||||
| Total related party receivable | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||
| Current liabilities: | |||||||||||||
| Related party accrued interest | |||||||||||||
| Related Party | |||||||||||||
| Total related party accrued interest | |||||||||||||
| Current portion of operating lease liabilities | |||||||||||||
| Nonrelated Party | |||||||||||||
| Total current portion of operating lease liabilities | |||||||||||||
| Trade accounts payable and accrued liabilities | |||||||||||||
| Related Party | |||||||||||||
| Total trade accounts payable and accrued liabilities | |||||||||||||
| Accrued liabilities | |||||||||||||
| Due to related party | |||||||||||||
| Accrued compensation – related party | |||||||||||||
| Advance payable to related party | |||||||||||||
| Total current liabilities | |||||||||||||
| Non-current operating lease liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Stockholders’ Equity | |||||||||||||
| Common Stock, $0.0001 par value; 100,000,000 shares authorized, 42,022,087 and 41,938,587 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively. | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total stockholders’ equity | |||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||
Loading...
